Ixchelsis Limited
Records under this name other than patents Ixchelsis Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Ixchelsis Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,557,131 | Substituted Triazole Derivatives as Oxytocin Antagonists Term ended Term ended Jun 17, 2026 · High confidence | Term ended | Term ended Jun 17, 2026 | High confidence |
| US 9,023,872 | Substituted Triazole Derivatives as Oxytocin Antagonists Term ended Term ended Jan 20, 2026 · High confidence | Term ended | Term ended Jan 20, 2026 | High confidence |
| US 10,150,752 | Substituted Triazole Derivatives as Oxytocin Antagonists Term ended Term ended Jan 20, 2026 · Medium confidence | Term ended | Term ended Jan 20, 2026 | Medium confidence |
| US 9,394,278 | Substituted Triazole Derivatives as Oxytocin Antagonists Lapsed on the fee record Ended Jul 19, 2024 · High confidence | Lapsed on the fee record | Ended Jul 19, 2024 | High confidence |
| US 8,207,198 | Substituted Triazole Derivatives as Oxytocin Antagonists Lapsed on the fee record Ended Jun 26, 2024 · High confidence | Lapsed on the fee record | Ended Jun 26, 2024 | High confidence |